pISSN 1226-6051
eISSN 2508-786X

Table. 5.

Table. 5.

Appropriateness of the local environmental impact for adopting the guideline

All respondents (n=94)aWork sitesWork departments

Clinical trial centers (n=21)Pharmaceutical companies (n=51)Clinical research organizations (n=11)Clinical trial management (n=18)Approval and registration (n=45)Research and development (n=20)
Systemic/Political impactb3.77±0.663.90±0.773.73±0.673.91±0.303.78±0.883.80±0.513.80±0.77
 Appropriatec90 (95.7%)20 (95.2%)49 (96.1%)11 (100%)17 (94.4%)44 (97.8%)19 (95.0%)
 Goodd68 (72.3%)16 (76.2%)35 (68.6%)10 (90.9%)11 (61.1%)36 (80.0%)14 (70.0%)
Academic/Technical impactb3.76±0.703.95±0.503.73±0.723.64±0.923.78±0.733.78±0.703.75±0.72
 Appropriate92 (97.9%)21 (100%)50 (98.0%)10 (90.9%)18 (100%)44 (97.8%)19 (95.0%)
 Good64 (68.1%)18 (85.7%)31 (60.8%)9 (81.8%)11 (61.1%)33 (73.3%)14 (70.0%)
industrial/economic impactb3.50±0.763.86±0.663.37±0.773.55±0.933.61±0.853.67±0.713.10±0.79e
 Appropriate86 (91.5%)21 (100%)44 (86.3%)10 (90.9%)17 (94.4%)43 (95.6%)15 (75.0%)
 Good51 (54.3%)15 (71.4%)24 (47.1%)8 (72.7%)9 (50.0%)31 (68.9%)7 (35.0%)

The demographic table contains the information about 83 respondents because 11 people skipped answering the personal information

The results are given as mean±SD

The criteria appropriate is defined with the score of 3-point or more and given as N (%).

The criteria good is defined with the score of 4-point or more and given as N (%).

The score of Research and Development were significantly different from that of Approval and Registration by a post hoc Bonferroni corrected Mann-Whitney U-test (p < 0.05).

Korean J Clin Pharm 2019;29:267-77 https://doi.org/10.24304/kjcp.2019.29.4.267
© 2019 Korean J Clin Pharm